epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
Apitegromab
apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Abilify Maintena

aripiprazole monthly injection

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Dementia-Related Psychosis

not approved for dementia-related psychosis; incr. mortality risk in elderly patients on antipsychotic tx for dementia-related psychosis; most deaths due to cardiovascular or infectious events

Adult Dosing .

Dosage forms:  INJ (pre-filled syringe): 300 mg per 1.5 mL, 400 mg per 2 mL; INJ (vial): 300 mg per 1.5 mL, 400 mg per 2 mL

schizophrenia

[1-day initiation regimen]
Dose: 400 mg IM qmo; Start: after establishing tolerability with PO aripiprazole; give 400 mg IM x2 plus aripiprazole 20 mg PO x1; Info: may decr. dose to 300 mg IM qmo; in CYP2D6 poor metabolizers, start 300 mg IM x2 plus aripiprazole 20 mg PO x1, then 300 mg IM qmo; see pkg insert for missed dose recommendations; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
[14-day initiation regimen]
Dose: 400 mg IM qmo; Start: after establishing tolerability with PO aripiprazole; overlap PO antipsychotic tx x14 days; Info: may decr. dose to 300 mg IM qmo; in CYP2D6 poor metabolizers, give 300 mg IM qmo; see pkg insert for missed dose recommendations; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC

bipolar I disorder, maintenance tx

[1-day initiation regimen]
Dose: 400 mg IM qmo; Start: after establishing tolerability with PO aripiprazole; give 400 mg IM x2 plus aripiprazole 20 mg PO x1; Info: may decr. dose to 300 mg IM qmo; in CYP2D6 poor metabolizers, start 300 mg IM x2 plus aripiprazole 20 mg PO x1, then 300 mg IM qmo; see pkg insert for missed dose recommendations; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC
[14-day initiation regimen]
Dose: 400 mg IM qmo; Start: after establishing tolerability with PO aripiprazole; overlap PO antipsychotic tx x14 days; Info: may decr. dose to 300 mg IM qmo; in CYP2D6 poor metabolizers, give 300 mg IM qmo; see pkg insert for missed dose recommendations; periodically reassess need for tx; D/C if ANC <1000; consider D/C if unexplained decr. in WBC

renal dosing

[see below]
CrCl >15: no adjustment; CrCl <15: not defined
HD/PD: not defined

hepatic dosing

[no adjustment]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@5f674e5b
  • hypersensitivity to drug or ingredient
  • caution: CYP2D6 poor metabolizers
  • caution: patients <25 yo (depression use)
  • caution: elderly patients
  • caution: psychosis, dementia-associated
  • caution: cerebrovascular disease
  • caution: cardiovascular disease
  • caution: MI history
  • caution: ischemic heart disease
  • caution: heart failure
  • caution: hypovolemia
  • caution: dehydration
  • caution: hypotension
  • caution: aspiration pneumonia risk
  • caution: seizure history
  • caution: seizure risk
  • caution: diabetes mellitus
  • caution: diabetes mellitus risk
  • caution: environmental temperature, high
  • caution: leukopenia
  • caution: leukopenia history, drug-induced
  • caution: neutropenia
  • caution: neutropenia history, drug-induced
  • caution: PKU (phenylalanine-containing form)

Drug Interactions .

Overview

aripiprazole monthly injection

atypical antipsychotic

Interaction Characteristics:
  • CYP2D6 substrate
  • CYP3A4 substrate
  • CNS depression
  • decreases central histamine effects
  • extrapyramidal effects
  • hyperglycemic effects
  • hyperthermia
  • hypotensive effects
  • lowers seizure threshold
Other Info
  • drug interactions apply only to Abilify Maintena; see other aripiprazole products for potentially relevant interactions
  • aripiprazole is a substrate of CYP2D6 and CYP3A4; drug interaction guidance may vary with CYP450 inhibitors if patient is CYP2D6 poor metabolizer (PM)

Avoid/Use Alternative

  • adagrasib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    adagrasib
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + adagrasib

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • aldesleukin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + aldesleukin

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, seizures, severe or life-threatening hypotension, including orthostasis (additive effects)

  • amifampridine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    amifampridine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + amifampridine

    consider alternative: combo may incr. risk of seizures (additive effects)

  • apalutamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    apalutamide
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + apalutamide

    avoid combo if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • aripiprazole bimonthly injection
  • Abilify Maintena (aripiprazole monthly injection)
    +
    aripiprazole bimonthly injection
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + aripiprazole bimonthly injection

    avoid combo after tx initiation: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole lauroxil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    aripiprazole lauroxil
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + aripiprazole lauroxil

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole monthly injection
  • Abilify Maintena (aripiprazole monthly injection)
    +
    aripiprazole monthly injection
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + aripiprazole monthly injection

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole oral
  • Abilify Maintena (aripiprazole monthly injection)
    +
    aripiprazole oral
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + aripiprazole oral

    avoid combo after tx initiation: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • asenapine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    asenapine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + asenapine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • atazanavir
  • Abilify Maintena (aripiprazole monthly injection)
    +
    atazanavir
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + atazanavir

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • benztropine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    benztropine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + benztropine

    consider alternative: combo may incr. risk of hyperthermia, including life-threatening (additive effects)

  • brexpiprazole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    brexpiprazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + brexpiprazole

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • bupropion
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bupropion
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + bupropion

    1-DAY START REGIMEN: consider lower bupropion doses; for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also combined w/ strong CYP3A4 inhibitor, avoid combo; 14-DAY START REGIMEN: consider lower bupropion doses; for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also combined w/ strong CYP3A4 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of seizures, other adverse effects (hepatic metabolism inhibited, additive effects)

  • butalbital
  • Abilify Maintena (aripiprazole monthly injection)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + butalbital

    avoid combo: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • carbamazepine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    carbamazepine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + carbamazepine

    avoid combo if concurrent use >14 days; otherwise, monitor BP: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment, hypotension, including syncope; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • cariprazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cariprazine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + cariprazine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • ceritinib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ceritinib
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + ceritinib

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • chloramphenicol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chloramphenicol
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + chloramphenicol

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • clarithromycin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clarithromycin
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + clarithromycin

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • clonidine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clonidine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + clonidine

    if ADHD use, avoid combo; otherwise, monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • clozapine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clozapine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + clozapine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, seizures, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • cobicistat
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cobicistat
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + cobicistat

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • codeine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    codeine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + codeine

    avoid combo if antitussive use; otherwise, monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • dacomitinib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dacomitinib
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + dacomitinib

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also combined w/ strong CYP3A4 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also combined w/ strong CYP3A4 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • doxylamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    doxylamine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + doxylamine

    avoid combo if doxylamine use for pregnancy-related nausea/vomiting; otherwise, caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • encorafenib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    encorafenib
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + encorafenib

    avoid combo if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • enzalutamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    enzalutamide
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + enzalutamide

    avoid combo if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • ethanol (alcoholic beverage)
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + ethanol (alcoholic beverage)

    avoid combo: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis (additive effects)

  • ethanol injection
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ethanol injection
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + ethanol injection

    use alternative or monitor respiratory rate, BP: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis (additive effects)

  • fluoxetine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fluoxetine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + fluoxetine

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also combined w/ strong CYP3A4 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also combined w/ strong CYP3A4 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited)

  • fosphenytoin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fosphenytoin
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + fosphenytoin

    avoid combo if concurrent use >14 days; otherwise, caution advised: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • haloperidol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    haloperidol
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + haloperidol

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hypotension, including orthostasis (additive effects)

  • hydrocodone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    hydrocodone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + hydrocodone

    avoid combo if antitussive use; otherwise, monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • idelalisib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    idelalisib
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + idelalisib

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • iloperidone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    iloperidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + iloperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • iohexol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    iohexol
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + iohexol

    avoid combo if intrathecal iohexol use: combo may incr. risk of seizures (additive effects)

  • isocarboxazid
  • Abilify Maintena (aripiprazole monthly injection)
    +
    isocarboxazid
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + isocarboxazid

    use alternative during and x10 days after isocarboxazid use: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • itraconazole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    itraconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + itraconazole

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo during and x2wk after itraconazole tx; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole dose by 100 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ivosidenib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ivosidenib
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + ivosidenib

    avoid combo if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • kava
  • Abilify Maintena (aripiprazole monthly injection)
    +
    kava
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + kava

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • ketoconazole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ketoconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + ketoconazole

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo during and up to 1wk after ketoconazole tx; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole dose by 100 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • kratom
  • Abilify Maintena (aripiprazole monthly injection)
    +
    kratom
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + kratom

    use alternative or monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • levoketoconazole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    levoketoconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + levoketoconazole

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • lofexidine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + lofexidine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • lonafarnib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lonafarnib
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + lonafarnib

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • lopinavir/ritonavir
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lopinavir/ ritonavir
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + lopinavir/ ritonavir

    consider alternative if concurrent use >14 days: combo may incr. or decr. aripiprazole levels, incr. risk of adverse effects or decr. efficacy (hepatic metabolism altered)

  • lumacaftor/ivacaftor
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + lumacaftor/ ivacaftor

    avoid combo if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • lumateperone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lumateperone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + lumateperone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • lurasidone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lurasidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + lurasidone

    use alternative or monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • mavorixafor
  • Abilify Maintena (aripiprazole monthly injection)
    +
    mavorixafor
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + mavorixafor

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also combined w/ strong CYP3A4 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also combined w/ strong CYP3A4 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • metaxalone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    metaxalone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + metaxalone

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • metoclopramide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    metoclopramide
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + metoclopramide

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • midazolam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    midazolam
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + midazolam

    use alternative or monitor BP, respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • mifepristone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    mifepristone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + mifepristone

    during and x14 days after daily mifepristone use: 1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole dose by 100 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • milsaperidone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    milsaperidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + milsaperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • mitotane
  • Abilify Maintena (aripiprazole monthly injection)
    +
    mitotane
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + mitotane

    avoid combo if concurrent use >14 days; otherwise, caution advised: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • nefazodone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nefazodone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + nefazodone

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited, additive effects)

  • nelfinavir
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nelfinavir
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + nelfinavir

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • olanzapine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    olanzapine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + olanzapine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • oxybate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    oxybate
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + oxybate

    use alternative or monitor respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, syncope (additive effects)

  • paliperidone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    paliperidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + paliperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • paroxetine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    paroxetine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + paroxetine

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also combined w/ strong CYP3A4 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also combined w/ strong CYP3A4 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited)

  • pentobarbital
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pentobarbital
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + pentobarbital

    avoid combo if concurrent use >14 days; otherwise, monitor BP, respiratory rate: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (hepatic metabolism induced; additive effects)

  • phenelzine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    phenelzine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + phenelzine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Abilify Maintena (aripiprazole monthly injection)
    +
    phenobarbital
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + phenobarbital

    avoid combo if concurrent use >14 days; otherwise, monitor BP, respiratory rate: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • phenytoin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    phenytoin
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + phenytoin

    avoid combo if concurrent use >14 days; otherwise, caution advised: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • pitolisant
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pitolisant
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + pitolisant

    avoid combo: combo may decr. pitolisant efficacy (antagonistic effects)

  • posaconazole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    posaconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + posaconazole

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • primidone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    primidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + primidone

    avoid combo if concurrent use >14 days; otherwise, monitor respiratory rate: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • promethazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    promethazine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + promethazine

    use alternative or monitor BP, respiratory rate; decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, seizures, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis (additive effects)

  • quetiapine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    quetiapine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + quetiapine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • quinidine (antiarrhythmic)
  • Abilify Maintena (aripiprazole monthly injection)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + quinidine (antiarrhythmic)

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also combined w/ strong CYP3A4 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also combined w/ strong CYP3A4 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • quinidine (CYP2D6 inhibitor)
  • Abilify Maintena (aripiprazole monthly injection)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + quinidine (CYP2D6 inhibitor)

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also combined w/ strong CYP3A4 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also combined w/ strong CYP3A4 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • relacorilant
  • Abilify Maintena (aripiprazole monthly injection)
    +
    relacorilant
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + relacorilant

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ribociclib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ribociclib
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + ribociclib

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • rifabutin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    rifabutin
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + rifabutin

    avoid combo if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • rifampin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    rifampin
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + rifampin

    avoid combo if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • risperidone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    risperidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + risperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • ritonavir
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ritonavir
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + ritonavir

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ropeginterferon alfa-2b
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ropeginterferon alfa-2b
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + ropeginterferon alfa-2b

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • scopolamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    scopolamine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + scopolamine

    use alternative: combo may increase risk of CNS depression, psychomotor impairment, hyperthermia, including life-threatening (additive effects)

  • St. John's wort
  • Abilify Maintena (aripiprazole monthly injection)
    +
    St. John's wort
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + St. John's wort

    avoid combo if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • terbinafine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    terbinafine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + terbinafine

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also combined w/ strong CYP3A4 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also combined w/ strong CYP3A4 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • thalidomide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    thalidomide
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + thalidomide

    use alternative or monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • tipranavir
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tipranavir
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + tipranavir

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • tradipitant
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tradipitant
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + tradipitant

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tranylcypromine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tranylcypromine
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + tranylcypromine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • trimethobenzamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    trimethobenzamide
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + trimethobenzamide

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • tucatinib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tucatinib
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + tucatinib

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • voriconazole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    voriconazole
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + voriconazole

    1-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg; if also CYP2D6 PM or if also combined w/ strong CYP2D6 inhibitor, avoid combo; 14-DAY START REGIMEN: for concurrent use >14 days, decr. IM aripiprazole 400 mg dose to 300 mg or decr. 300 mg dose to 200 mg; if also CYP2D6 PM, decr. IM aripiprazole dose to 200 mg; if also combined w/ strong CYP2D6 inhibitor, decr. IM aripiprazole 400 mg dose to 200 mg and decr. 300 mg dose to 160 mg: combo may incr. aripiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ziprasidone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ziprasidone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + ziprasidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • zuranolone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    zuranolone
    1 interaction

    Avoid/Use Alternative

    aripiprazole monthly injection + zuranolone

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Monitor/Modify Tx

  • acarbose
  • Abilify Maintena (aripiprazole monthly injection)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acebutolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + acebutolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • alfentanil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + alfentanil

    monitor BP, respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Abilify Maintena (aripiprazole monthly injection)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + aliskiren

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • alogliptin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alprazolam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    alprazolam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + alprazolam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • alprostadil intracavernous
  • Abilify Maintena (aripiprazole monthly injection)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension, including orthostasis (additive effects)

  • amantadine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + amantadine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + amifostine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • amiloride
  • Abilify Maintena (aripiprazole monthly injection)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + amiloride

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amitriptyline
  • Abilify Maintena (aripiprazole monthly injection)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + amitriptyline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • amlodipine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + amlodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amoxapine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + amoxapine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • apomorphine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + apomorphine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Abilify Maintena (aripiprazole monthly injection)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • aprocitentan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + aprocitentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • articaine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + articaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • atenolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + atenolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • avanafil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • azilsartan medoxomil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + azilsartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • baclofen intrathecal
  • Abilify Maintena (aripiprazole monthly injection)
    +
    baclofen intrathecal
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + baclofen intrathecal

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • benazepril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + benazepril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • berberine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + berberine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betaxolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + betaxolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betaxolol ophthalmic
  • Abilify Maintena (aripiprazole monthly injection)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bethanechol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + bethanechol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bexagliflozin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + bexagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bisoprolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + bisoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bortezomib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • brimonidine ophthalmic
  • Abilify Maintena (aripiprazole monthly injection)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • brimonidine topical
  • Abilify Maintena (aripiprazole monthly injection)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + brimonidine topical

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + bromocriptine

    monitor BP, glucose in type 2 diabetes mellitus pts: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bumetanide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + bumetanide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bupivacaine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + bupivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bupivacaine liposomal
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • buprenorphine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + buprenorphine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • butorphanol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + butorphanol

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • cabergoline
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • canagliflozin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + canagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • candesartan cilexetil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + candesartan cilexetil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • cannabis
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + cannabis

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • captopril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + captopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • carteolol ophthalmic
  • Abilify Maintena (aripiprazole monthly injection)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • carvedilol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + carvedilol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chlordiazepoxide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chlordiazepoxide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + chlordiazepoxide

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • chloroprocaine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + chloroprocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chlorothiazide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + chlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chlorpromazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + chlorpromazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • chlorthalidone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + chlorthalidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • cilostazol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + cilostazol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clevidipine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + clevidipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clobazam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clobazam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + clobazam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • clofarabine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + clofarabine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • clomipramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + clomipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, seizures, hyperthermia, hypotension, including orthostasis (additive effects)

  • clonazepam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clonazepam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + clonazepam

    monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • clorazepate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clorazepate
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + clorazepate

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • coenzyme Q-10
  • Abilify Maintena (aripiprazole monthly injection)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • colesevelam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dapagliflozin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + dapagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • daridorexant
  • Abilify Maintena (aripiprazole monthly injection)
    +
    daridorexant
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + daridorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • denileukin diftitox
  • Abilify Maintena (aripiprazole monthly injection)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Abilify Maintena (aripiprazole monthly injection)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + desflurane

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • desipramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + desipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • dexmedetomidine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + dexmedetomidine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + dexmedetomidine injection

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, severe or life-threatening hypotension, including orthostasis (additive effects)

  • diazepam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    diazepam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + diazepam

    monitor BP, respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • dihydrocodeine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + dihydrocodeine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • diltiazem
  • Abilify Maintena (aripiprazole monthly injection)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + diltiazem

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dinutuximab
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • dipyridamole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • doxazosin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + doxepin

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • dronabinol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + dronabinol

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • droperidol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    droperidol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + droperidol

    decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dulaglutide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duloxetine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + duloxetine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • empagliflozin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + empagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • enalapril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + enalapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enalaprilat
  • Abilify Maintena (aripiprazole monthly injection)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + enalaprilat

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • entacapone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + entacapone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + entrectinib

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • eplerenone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + eplerenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • epoprostenol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ertugliflozin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ertugliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • esketamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + esketamine

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • esmolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + esmolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • estazolam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    estazolam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + estazolam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • eszopiclone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    eszopiclone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + eszopiclone

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ethacrynic acid
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ethacrynic acid

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ethanol (in some formulations)
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ethanol (in some formulations)
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ethanol (in some formulations)

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etomidate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    etomidate
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + etomidate

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etripamil nasal
  • Abilify Maintena (aripiprazole monthly injection)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • exenatide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • felodipine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + felodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fenoldopam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + fenoldopam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fentanyl
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + fentanyl

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • ferumoxytol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ferumoxytol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flaxseed
  • Abilify Maintena (aripiprazole monthly injection)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + flaxseed

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flibanserin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + flibanserin

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • fluphenazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + fluphenazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis (additive effects)

  • flurazepam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    flurazepam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + flurazepam

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • fosinopril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + fosinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • foslevodopa
  • Abilify Maintena (aripiprazole monthly injection)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + foslevodopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • furosemide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + furosemide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • gabapentin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    gabapentin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + gabapentin

    monitor respiratory rate; consider decreasing gabapentin dose: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decrease seizure threshold)

  • gabapentin enacarbil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    gabapentin enacarbil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + gabapentin enacarbil

    monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • garlic
  • Abilify Maintena (aripiprazole monthly injection)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • gilteritinib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + gilteritinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • glimepiride
  • Abilify Maintena (aripiprazole monthly injection)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • guanfacine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + guanfacine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • hydralazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + hydralazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydrochlorothiazide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + hydrochlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydromorphone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + hydromorphone

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • hydroxyzine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    hydroxyzine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + hydroxyzine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ifosfamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ifosfamide

    D/C one or both drugs if encephalopathy occurs; otherwise, caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • iloprost
  • Abilify Maintena (aripiprazole monthly injection)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + iloprost

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + imipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • indapamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + indapamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • insulin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + insulin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • iopamidol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + iopamidol

    caution advised if intrathecal iopamidol use; consider holding aripiprazole at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • irbesartan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + irbesartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • iron sucrose
  • Abilify Maintena (aripiprazole monthly injection)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + iron sucrose

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isoflurane
  • Abilify Maintena (aripiprazole monthly injection)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + isoflurane

    monitor BP, respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • isosorbide dinitrate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isosorbide mononitrate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isradipine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + isradipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ketamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ketamine

    monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression (including life-threatening), psychomotor impairment (additive effects)

  • labetalol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + labetalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • landiolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + landiolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lemborexant
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lemborexant
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + lemborexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levobunolol ophthalmic
  • Abilify Maintena (aripiprazole monthly injection)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • levodopa
  • Abilify Maintena (aripiprazole monthly injection)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + levodopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • levorphanol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + levorphanol

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • lidocaine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + lidocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • linagliptin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • liraglutide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisinopril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + lisinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lithium
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + lithium

    D/C one or both drugs if encephalopathy occurs: combo may incr. risk of encephalopathic syndrome, extrapyramidal symptoms (additive effects)

  • lixisenatide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lorazepam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lorazepam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + lorazepam

    monitor BP, respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • losartan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + losartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • loxapine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + loxapine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • magnesium sulfate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • maraviroc
  • Abilify Maintena (aripiprazole monthly injection)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • meperidine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + meperidine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + mepivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • metformin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methadone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + methadone

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • methohexital
  • Abilify Maintena (aripiprazole monthly injection)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + methohexital

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • methyldopa
  • Abilify Maintena (aripiprazole monthly injection)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + methyldopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • methylene blue injection
  • Abilify Maintena (aripiprazole monthly injection)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • metolazone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + metolazone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • metoprolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + metoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • miglitol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milrinone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + milrinone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • minoxidil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + minoxidil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mirtazapine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + mirtazapine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • moexipril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + moexipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • molindone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + molindone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis (additive effects)

  • morphine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + morphine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nadolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nadolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nalbuphine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nalbuphine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nateglinide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nateglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nattokinase
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nattokinase

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • naxitamab
  • Abilify Maintena (aripiprazole monthly injection)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + naxitamab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nebivolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nebivolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nelarabine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nelarabine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nelarabine

    withhold nelarabine if Grade 2 or greater somnolence occurs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • niacin (vitamin B3)
  • Abilify Maintena (aripiprazole monthly injection)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nicardipine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nicardipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nifedipine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nifedipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nimodipine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nimodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nisoldipine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nisoldipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitric oxide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nitric oxide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitrite
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • nitroglycerin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • nortriptyline
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + nortriptyline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • obinutuzumab
  • Abilify Maintena (aripiprazole monthly injection)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + obinutuzumab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • oliceridine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + oliceridine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • olmesartan medoxomil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + olmesartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • opicapone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Abilify Maintena (aripiprazole monthly injection)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + opium

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • oxazepam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + oxazepam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • oxybutynin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    oxybutynin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + oxybutynin

    decr. dose of one or both drugs or consider oxybutynin transdermal patch: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; somnolence less likely with oxybutynin transdermal patch (additive effects)

  • oxycodone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + oxycodone

    monitor BP, respiratory rate; decr. oxycodone start dose by at least 50%, consider decr. aripiprazole dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • oxymorphone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + oxymorphone

    monitor BP, respiratory rate; decr. oxymorphone start dose by at least 50%, consider decr. aripiprazole dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pentamidine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + pentamidine

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • pentazocine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + pentazocine

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • perindopril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + perindopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • perphenazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + perphenazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, severe hypotension, including orthostasis, syncope (additive effects)

  • phenoxybenzamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + phenoxybenzamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phentolamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + phentolamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pindolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + pindolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pioglitazone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pramipexole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + pramipexole

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • pramlintide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pregabalin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pregabalin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + pregabalin

    monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • procarbazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + procarbazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • prochlorperazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + prochlorperazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis (additive effects)

  • propafenone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + propafenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • propofol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + propofol

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis (additive effects)

  • propranolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + propranolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • protriptyline
  • Abilify Maintena (aripiprazole monthly injection)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + protriptyline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • quazepam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    quazepam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + quazepam

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • quinapril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + quinapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ramipril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ramipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rasagiline
  • Abilify Maintena (aripiprazole monthly injection)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + rasagiline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • remifentanil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + remifentanil

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • remimazolam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + remimazolam

    monitor BP, respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • repaglinide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • riociguat
  • Abilify Maintena (aripiprazole monthly injection)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + riociguat

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ropinirole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ropinirole

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • ropivacaine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ropivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rosiglitazone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • Abilify Maintena (aripiprazole monthly injection)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + rotigotine transdermal

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • sacubitril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + safinamide

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • saxagliptin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selegiline
  • Abilify Maintena (aripiprazole monthly injection)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + selegiline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Abilify Maintena (aripiprazole monthly injection)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + selegiline transdermal

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • semaglutide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sevoflurane
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + sevoflurane

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • sildenafil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + sildenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • silodosin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sitagliptin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + sitagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sodium ferric gluconate complex
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sotagliflozin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sotalol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + sotalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sparsentan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + sparsentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + spironolactone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sufentanil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + sufentanil

    monitor BP, respiratory rate; decr. sufentanil start dose, consider decr. aripiprazole dose, use lowest effective doses: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • suvorexant
  • Abilify Maintena (aripiprazole monthly injection)
    +
    suvorexant
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + suvorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tadalafil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + tadalafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tagraxofusp
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + tagraxofusp

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tamsulosin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + tapentadol

    monitor respiratory rate, BP; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + taurine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • telmisartan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + telmisartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • temazepam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    temazepam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + temazepam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • terazosin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • thioridazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + thioridazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • thiothixene
  • Abilify Maintena (aripiprazole monthly injection)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + thiothixene

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • timolol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + timolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • timolol ophthalmic
  • Abilify Maintena (aripiprazole monthly injection)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tirzepatide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tizanidine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + tizanidine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + tolcapone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • torsemide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + torsemide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tramadol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + tramadol

    monitor BP, respiratory rate; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, seizures, severe hypotension, including orthostasis, syncope (additive effects)

  • trandolapril
  • Abilify Maintena (aripiprazole monthly injection)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + trandolapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trazodone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + trazodone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • triamterene
  • Abilify Maintena (aripiprazole monthly injection)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + triamterene

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • triazolam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    triazolam
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + triazolam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis (additive effects)

  • trifluoperazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + trifluoperazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, severe hypotension, including orthostasis (additive effects)

  • trimipramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + trimipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis (additive effects)

  • valsartan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + valsartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vardenafil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + vardenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • verapamil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + verapamil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vosoritide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + vosoritide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • yohimbe
  • Abilify Maintena (aripiprazole monthly injection)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + yohimbe

    monitor BP, especially w/ high yohimbe doses: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • zaleplon
  • Abilify Maintena (aripiprazole monthly injection)
    +
    zaleplon
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + zaleplon

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ziconotide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ziconotide
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + ziconotide

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zolpidem
  • Abilify Maintena (aripiprazole monthly injection)
    +
    zolpidem
    1 interaction

    Monitor/Modify Tx

    aripiprazole monthly injection + zolpidem

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Caution Advised

  • 5-HTP
  • Abilify Maintena (aripiprazole monthly injection)
    +
    5-HTP
    1 interaction

    Caution Advised

    aripiprazole monthly injection + 5-HTP

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • acetazolamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    acetazolamide
    1 interaction

    Caution Advised

    aripiprazole monthly injection + acetazolamide

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, aripiprazole may decr. seizure threshold)

  • aclidinium inhaled
  • Abilify Maintena (aripiprazole monthly injection)
    +
    aclidinium inhaled
    1 interaction

    Caution Advised

    aripiprazole monthly injection + aclidinium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • allopurinol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    allopurinol
    1 interaction

    Caution Advised

    aripiprazole monthly injection + allopurinol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • almotriptan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    almotriptan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + almotriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • atropine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    atropine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + atropine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • baclofen
  • Abilify Maintena (aripiprazole monthly injection)
    +
    baclofen
    1 interaction

    Caution Advised

    aripiprazole monthly injection + baclofen

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • belladonna alkaloids
  • Abilify Maintena (aripiprazole monthly injection)
    +
    belladonna alkaloids
    1 interaction

    Caution Advised

    aripiprazole monthly injection + belladonna alkaloids

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • bosentan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    bosentan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + bosentan

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • botulinum toxin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    botulinum toxin
    1 interaction

    Caution Advised

    aripiprazole monthly injection + botulinum toxin

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • brivaracetam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    brivaracetam
    1 interaction

    Caution Advised

    aripiprazole monthly injection + brivaracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • brompheniramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    brompheniramine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + brompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • buspirone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    buspirone
    1 interaction

    Caution Advised

    aripiprazole monthly injection + buspirone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • busulfan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    busulfan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + busulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • cannabidiol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cannabidiol
    1 interaction

    Caution Advised

    aripiprazole monthly injection + cannabidiol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • carbinoxamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    carbinoxamine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + carbinoxamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • carisoprodol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    carisoprodol
    1 interaction

    Caution Advised

    aripiprazole monthly injection + carisoprodol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cenobamate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cenobamate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + cenobamate

    caution advised: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • cetirizine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cetirizine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + cetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chamomile, German
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chamomile, German
    1 interaction

    Caution Advised

    aripiprazole monthly injection + chamomile, German

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chlophedianol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chlophedianol
    1 interaction

    Caution Advised

    aripiprazole monthly injection + chlophedianol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chlorambucil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chlorambucil
    1 interaction

    Caution Advised

    aripiprazole monthly injection + chlorambucil

    caution advised: combo may incr. risk of seizures (additive effects)

  • chlorcyclizine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chlorcyclizine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + chlorcyclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chloroquine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chloroquine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + chloroquine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • chlorpheniramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chlorpheniramine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + chlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chlorzoxazone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    chlorzoxazone
    1 interaction

    Caution Advised

    aripiprazole monthly injection + chlorzoxazone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • citalopram
  • Abilify Maintena (aripiprazole monthly injection)
    +
    citalopram
    1 interaction

    Caution Advised

    aripiprazole monthly injection + citalopram

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • clemastine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clemastine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + clemastine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • clidinium
  • Abilify Maintena (aripiprazole monthly injection)
    +
    clidinium
    1 interaction

    Caution Advised

    aripiprazole monthly injection + clidinium

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • cyclobenzaprine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cyclobenzaprine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + cyclobenzaprine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • cyproheptadine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    cyproheptadine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + cyproheptadine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dabrafenib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dabrafenib
    1 interaction

    Caution Advised

    aripiprazole monthly injection + dabrafenib

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • dantrolene
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dantrolene
    1 interaction

    Caution Advised

    aripiprazole monthly injection + dantrolene

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • darifenacin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    darifenacin
    1 interaction

    Caution Advised

    aripiprazole monthly injection + darifenacin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • desvenlafaxine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    desvenlafaxine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + desvenlafaxine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • deutetrabenazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    deutetrabenazine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + deutetrabenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dexbrompheniramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dexbrompheniramine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + dexbrompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dexchlorpheniramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dexchlorpheniramine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + dexchlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dichlorphenamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dichlorphenamide
    1 interaction

    Caution Advised

    aripiprazole monthly injection + dichlorphenamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dicyclomine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dicyclomine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + dicyclomine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • difelikefalin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    difelikefalin
    1 interaction

    Caution Advised

    aripiprazole monthly injection + difelikefalin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • difenoxin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    difenoxin
    1 interaction

    Caution Advised

    aripiprazole monthly injection + difenoxin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dimenhydrinate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    dimenhydrinate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + dimenhydrinate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • diphenhydramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    diphenhydramine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + diphenhydramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • diphenoxylate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    diphenoxylate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + diphenoxylate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • disopyramide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    disopyramide
    1 interaction

    Caution Advised

    aripiprazole monthly injection + disopyramide

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • domperidone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    domperidone
    1 interaction

    Caution Advised

    aripiprazole monthly injection + domperidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • doxepin topical
  • Abilify Maintena (aripiprazole monthly injection)
    +
    doxepin topical
    1 interaction

    Caution Advised

    aripiprazole monthly injection + doxepin topical

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • efavirenz
  • Abilify Maintena (aripiprazole monthly injection)
    +
    efavirenz
    1 interaction

    Caution Advised

    aripiprazole monthly injection + efavirenz

    caution advised: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • eletriptan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    eletriptan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + eletriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • elinzanetant
  • Abilify Maintena (aripiprazole monthly injection)
    +
    elinzanetant
    1 interaction

    Caution Advised

    aripiprazole monthly injection + elinzanetant

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • escitalopram
  • Abilify Maintena (aripiprazole monthly injection)
    +
    escitalopram
    1 interaction

    Caution Advised

    aripiprazole monthly injection + escitalopram

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • eslicarbazepine acetate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    eslicarbazepine acetate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + eslicarbazepine acetate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • ethosuximide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ethosuximide
    1 interaction

    Caution Advised

    aripiprazole monthly injection + ethosuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • etravirine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    etravirine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + etravirine

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • felbamate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    felbamate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + felbamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • fenfluramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fenfluramine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + fenfluramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • fesoterodine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fesoterodine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + fesoterodine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • fexinidazole
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fexinidazole
    1 interaction

    Caution Advised

    aripiprazole monthly injection + fexinidazole

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • flavoxate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    flavoxate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + flavoxate

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • fluvoxamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    fluvoxamine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + fluvoxamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • frovatriptan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    frovatriptan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + frovatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • galantamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    galantamine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + galantamine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • ganaxolone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ganaxolone
    1 interaction

    Caution Advised

    aripiprazole monthly injection + ganaxolone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • glofitamab
  • Abilify Maintena (aripiprazole monthly injection)
    +
    glofitamab
    1 interaction

    Caution Advised

    aripiprazole monthly injection + glofitamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • glycopyrrolate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    glycopyrrolate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + glycopyrrolate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • glycopyrrolate inhaled
  • Abilify Maintena (aripiprazole monthly injection)
    +
    glycopyrrolate inhaled
    1 interaction

    Caution Advised

    aripiprazole monthly injection + glycopyrrolate inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • glycopyrronium topical
  • Abilify Maintena (aripiprazole monthly injection)
    +
    glycopyrronium topical
    1 interaction

    Caution Advised

    aripiprazole monthly injection + glycopyrronium topical

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • homatropine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    homatropine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + homatropine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • hydroxychloroquine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    hydroxychloroquine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + hydroxychloroquine

    caution advised: combo may incr. risk of seizures (additive effects)

  • hyoscyamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    hyoscyamine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + hyoscyamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ipratropium inhaled
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ipratropium inhaled
    1 interaction

    Caution Advised

    aripiprazole monthly injection + ipratropium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • lacosamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lacosamide
    1 interaction

    Caution Advised

    aripiprazole monthly injection + lacosamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • lamotrigine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lamotrigine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + lamotrigine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • levetiracetam
  • Abilify Maintena (aripiprazole monthly injection)
    +
    levetiracetam
    1 interaction

    Caution Advised

    aripiprazole monthly injection + levetiracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • levocetirizine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    levocetirizine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + levocetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levomilnacipran
  • Abilify Maintena (aripiprazole monthly injection)
    +
    levomilnacipran
    1 interaction

    Caution Advised

    aripiprazole monthly injection + levomilnacipran

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • linvoseltamab
  • Abilify Maintena (aripiprazole monthly injection)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    aripiprazole monthly injection + linvoseltamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • lorlatinib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    lorlatinib
    1 interaction

    Caution Advised

    aripiprazole monthly injection + lorlatinib

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • magnesium citrate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    magnesium citrate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + magnesium citrate

    caution advised, especially if magnesium citrate bowel prep use: combo may incr. risk of seizures (additive effects)

  • mavacamten
  • Abilify Maintena (aripiprazole monthly injection)
    +
    mavacamten
    1 interaction

    Caution Advised

    aripiprazole monthly injection + mavacamten

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • meclizine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    meclizine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + meclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • melatonin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    melatonin
    1 interaction

    Caution Advised

    aripiprazole monthly injection + melatonin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • meprobamate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    meprobamate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + meprobamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methocarbamol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    methocarbamol
    1 interaction

    Caution Advised

    aripiprazole monthly injection + methocarbamol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methscopolamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    methscopolamine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + methscopolamine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • methsuximide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    methsuximide
    1 interaction

    Caution Advised

    aripiprazole monthly injection + methsuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • metyrapone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    metyrapone
    1 interaction

    Caution Advised

    aripiprazole monthly injection + metyrapone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • metyrosine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    metyrosine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + metyrosine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • milnacipran
  • Abilify Maintena (aripiprazole monthly injection)
    +
    milnacipran
    1 interaction

    Caution Advised

    aripiprazole monthly injection + milnacipran

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mitapivat
  • Abilify Maintena (aripiprazole monthly injection)
    +
    mitapivat
    1 interaction

    Caution Advised

    aripiprazole monthly injection + mitapivat

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • modafinil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    modafinil
    1 interaction

    Caution Advised

    aripiprazole monthly injection + modafinil

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • mosunetuzumab
  • Abilify Maintena (aripiprazole monthly injection)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    aripiprazole monthly injection + mosunetuzumab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mycophenolate mofetil
  • Abilify Maintena (aripiprazole monthly injection)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    aripiprazole monthly injection + mycophenolate mofetil

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • nafcillin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    nafcillin
    1 interaction

    Caution Advised

    aripiprazole monthly injection + nafcillin

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • naltrexone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    naltrexone
    1 interaction

    Caution Advised

    aripiprazole monthly injection + naltrexone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • naratriptan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    naratriptan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + naratriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • orphenadrine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    orphenadrine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + orphenadrine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • oxcarbazepine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + oxcarbazepine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • pacritinib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pacritinib
    1 interaction

    Caution Advised

    aripiprazole monthly injection + pacritinib

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • passion flower
  • Abilify Maintena (aripiprazole monthly injection)
    +
    passion flower
    1 interaction

    Caution Advised

    aripiprazole monthly injection + passion flower

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • perampanel
  • Abilify Maintena (aripiprazole monthly injection)
    +
    perampanel
    1 interaction

    Caution Advised

    aripiprazole monthly injection + perampanel

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • pexidartinib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pexidartinib
    1 interaction

    Caution Advised

    aripiprazole monthly injection + pexidartinib

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • pheniramine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pheniramine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + pheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • pimozide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pimozide
    1 interaction

    Caution Advised

    aripiprazole monthly injection + pimozide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms (additive effects)

  • polyethylene glycol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    polyethylene glycol
    1 interaction

    Caution Advised

    aripiprazole monthly injection + polyethylene glycol

    caution advised, especially if polyethylene glycol bowel prep use: combo may incr. risk of seizures (additive effects)

  • polyethylene glycol/electrolytes
  • Abilify Maintena (aripiprazole monthly injection)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Caution Advised

    aripiprazole monthly injection + polyethylene glycol/ electrolytes

    caution advised: combo may incr. risk of seizures (additive effects)

  • pyrilamine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    pyrilamine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + pyrilamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ramelteon
  • Abilify Maintena (aripiprazole monthly injection)
    +
    ramelteon
    1 interaction

    Caution Advised

    aripiprazole monthly injection + ramelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • repotrectinib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    repotrectinib
    1 interaction

    Caution Advised

    aripiprazole monthly injection + repotrectinib

    caution advised: combo may decr. aripiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • revefenacin inhaled
  • Abilify Maintena (aripiprazole monthly injection)
    +
    revefenacin inhaled
    1 interaction

    Caution Advised

    aripiprazole monthly injection + revefenacin inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • rifapentine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    rifapentine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + rifapentine

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • rivastigmine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    rivastigmine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + rivastigmine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • rizatriptan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    rizatriptan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + rizatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • rufinamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    rufinamide
    1 interaction

    Caution Advised

    aripiprazole monthly injection + rufinamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • selinexor
  • Abilify Maintena (aripiprazole monthly injection)
    +
    selinexor
    1 interaction

    Caution Advised

    aripiprazole monthly injection + selinexor

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • sertraline
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sertraline
    1 interaction

    Caution Advised

    aripiprazole monthly injection + sertraline

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • sodium picosulfate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sodium picosulfate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + sodium picosulfate

    caution advised: combo may incr. risk of seizures (additive effects)

  • sofpironium topical
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sofpironium topical
    1 interaction

    Caution Advised

    aripiprazole monthly injection + sofpironium topical

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • solifenacin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    solifenacin
    1 interaction

    Caution Advised

    aripiprazole monthly injection + solifenacin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • sotorasib
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sotorasib
    1 interaction

    Caution Advised

    aripiprazole monthly injection + sotorasib

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • stiripentol
  • Abilify Maintena (aripiprazole monthly injection)
    +
    stiripentol
    1 interaction

    Caution Advised

    aripiprazole monthly injection + stiripentol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • sulfate bowel prep
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sulfate bowel prep
    1 interaction

    Caution Advised

    aripiprazole monthly injection + sulfate bowel prep

    caution advised: combo may incr. risk of seizures (additive effects)

  • sumatriptan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    sumatriptan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + sumatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tasimelteon
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tasimelteon
    1 interaction

    Caution Advised

    aripiprazole monthly injection + tasimelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tetrabenazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tetrabenazine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + tetrabenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • thiotepa
  • Abilify Maintena (aripiprazole monthly injection)
    +
    thiotepa
    1 interaction

    Caution Advised

    aripiprazole monthly injection + thiotepa

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tiagabine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tiagabine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + tiagabine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • tiotropium inhaled
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tiotropium inhaled
    1 interaction

    Caution Advised

    aripiprazole monthly injection + tiotropium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • tolterodine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    tolterodine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + tolterodine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • topiramate
  • Abilify Maintena (aripiprazole monthly injection)
    +
    topiramate
    1 interaction

    Caution Advised

    aripiprazole monthly injection + topiramate

    caution advised, especially in Peds pts: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • treosulfan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    treosulfan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + treosulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • trihexyphenidyl
  • Abilify Maintena (aripiprazole monthly injection)
    +
    trihexyphenidyl
    1 interaction

    Caution Advised

    aripiprazole monthly injection + trihexyphenidyl

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • triprolidine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    triprolidine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + triprolidine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • trospium
  • Abilify Maintena (aripiprazole monthly injection)
    +
    trospium
    1 interaction

    Caution Advised

    aripiprazole monthly injection + trospium

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • umeclidinium inhaled
  • Abilify Maintena (aripiprazole monthly injection)
    +
    umeclidinium inhaled
    1 interaction

    Caution Advised

    aripiprazole monthly injection + umeclidinium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • valbenazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    valbenazine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + valbenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valerian
  • Abilify Maintena (aripiprazole monthly injection)
    +
    valerian
    1 interaction

    Caution Advised

    aripiprazole monthly injection + valerian

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valproic acid
  • Abilify Maintena (aripiprazole monthly injection)
    +
    valproic acid
    1 interaction

    Caution Advised

    aripiprazole monthly injection + valproic acid

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • venlafaxine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    venlafaxine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + venlafaxine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • vigabatrin
  • Abilify Maintena (aripiprazole monthly injection)
    +
    vigabatrin
    1 interaction

    Caution Advised

    aripiprazole monthly injection + vigabatrin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

  • vilazodone
  • Abilify Maintena (aripiprazole monthly injection)
    +
    vilazodone
    1 interaction

    Caution Advised

    aripiprazole monthly injection + vilazodone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • viloxazine
  • Abilify Maintena (aripiprazole monthly injection)
    +
    viloxazine
    1 interaction

    Caution Advised

    aripiprazole monthly injection + viloxazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zolmitriptan
  • Abilify Maintena (aripiprazole monthly injection)
    +
    zolmitriptan
    1 interaction

    Caution Advised

    aripiprazole monthly injection + zolmitriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zonisamide
  • Abilify Maintena (aripiprazole monthly injection)
    +
    zonisamide
    1 interaction

    Caution Advised

    aripiprazole monthly injection + zonisamide

    caution advised, especially in Peds pts: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; may alter seizure control (additive effects; antagonistic effects, aripiprazole may decr. seizure threshold)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@2cf4bb61
  • hypersensitivity reaction
  • anaphylaxis
  • drug reaction with eosinophilia and systemic symptoms
  • neuroleptic malignant syndrome
  • extrapyramidal symptoms
  • tardive dyskinesia
  • dystonia
  • stroke
  • TIA
  • syncope
  • hypotension, orthostatic
  • seizures
  • hyperglycemia
  • diabetes mellitus
  • dysphagia, severe
  • aspiration
  • hyperthermia
  • hypothermia
  • pancreatitis
  • blood dyscrasia
  • leukopenia
  • neutropenia
  • agranulocytosis
  • rhabdomyolysis
  • suicidality
  • depression exacerbation

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@48d64685
  • headache
  • dyslipidemia
  • weight gain
  • extrapyramidal symptoms
  • akathisia
  • somnolence
  • injection site reaction (IM use)
  • insomnia
  • hyperglycemia
  • anxiety
  • fatigue
  • nausea
  • vomiting
  • restlessness
  • constipation
  • dizziness
  • tremor
  • fever (peds patients)
  • URI
  • blurred vision
  • sialorrhea (peds patients)
  • appetite changes
  • xerostomia
  • arthralgia
  • myalgia
  • diarrhea (peds patients)
  • impaired body temperature regulation
  • compulsive behaviors

Safety/Monitoring .

Monitoring Parameters
fasting glucose at baseline if diabetes risk factors, then periodically; CBC with diff frequently during initial tx if pre-existing or history of leukopenia/neutropenia; weight; consider orthostatic vital signs if hypotension risk

Look/Sound-Alike Drug Names
ARIPiprazole confused with: lansoprazole; omeprazole; RABEprazole

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy, especially in 3rd trimester; risk of teratogenicity not expected based on limited human data, though risk of neonatal extrapyramidal and withdrawal symptoms based on human data with antipsychotics

Pregnancy Registry

encourage patients to enroll in National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding, monitor infant for dehydration and poor wt. gain; possible risk of infant harm based on limited human data; decr. milk production based on human data and decr. prolactin levels

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@a2e930e

Metabolism: for aripiprazole: liver; CYP450: 2D6, 3A4 substrate; Info: active metabolite; CYP2D6 poor metabolizers have 60% increased active drug exposure

Excretion: for aripiprazole: feces 55% (18% unchanged), urine 25% (<1% unchanged); Half-life: 75h (IR form, CYP2D6 extensive metabolizers), 146h (IR form, CYP2D6 poor metabolizers), 29.9-46.5 days (1-mo IM form), 21 days (bimonthly IM form)

Subclass: Antipsychotics, 2nd generation ; Bipolar Disorder

Mechanism of Action
for aripiprazole: exact mechanism of action unknown; partially agonizes dopamine D2 and serotonin 5-HT1A receptors, antagonizes serotonin 5-HT2A receptors

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Otsuka America Pharmaceutical Co. and Lundbeck Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@19867072

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

intramuscular powder for injection, extended release:

  • 300 mg (1 syringe, dual chamber): $1,837.00
  • 400 mg (1 syringe, dual chamber): $2,446.00

intramuscular powder for injection, extended release:

  • 300 mg (1 vial): $1,837.00
  • 400 mg (1 vial): $2,446.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information